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Temporal ocular coherence tomography-measured
changes in anterior chamber angle and diurnal
intraocular pressure after laser iridoplasty: IMPACT
study
Rupert R A Bourne,1,2 Ivailo Zhekov,1,2 Shahina Pardhan1
ABSTRACT
Aims To evaluate temporal change in anterior chamber
angle anatomy following argon laser peripheral
iridoplasty (ALPI) in eyes with occludable angles
postlaser peripheral iridotomy (LPI) compared with
control eyes. Additionally, the effect on diurnal
intraocular pressure (DIOP) ﬂuctuation (maximum-
minimum IOP) was investigated.
Methods Twenty-two patients with bilateral primary
angle closure/suspects with gonioscopically occludable
anterior chamber angles following LPI were randomised
to receive ALPI (n=11) or no further treatment (n=11).
Angle opening distance (AOD), trabecular-iris angle,
angle recess area and trabecular-iris space area were
measured over eight sections with swept-source anterior
segment optical coherence tomography and DIOP was
measured pre-LPI and repeated at 3 months after ALPI
(hourly measures).
Results All angle parameters increased following ALPI.
This change was maintained for 3 months in seven of
the eight sections (eg, inferotemporal AOD500 increased
by 0.063 mm, p=0.004 at 1 day; 0.051 mm, p=0.029
at 1 week; 0.059 mm, p=0.006 at 6 weeks and
0.056 mm, p=0.011 at 3 months). The only exception
was in the inferior sector (eg, AOD500 increased by
0.041 mm, p=0.025 at 1 day and by 0.029 mm,
p=0.054 at 3 months). DIOP at 3 months was
signiﬁcantly reduced (5.04 mm Hg; ±1.61 mm Hg)
compared with controls (6.61 mm Hg; ±1.63 mm Hg).
Maximum IOP was signiﬁcantly greater in the non-ALPI
group (1.87 mm Hg, p=0.026).
Conclusions ALPI widened all angle sections in eyes
that remained occludable post-LPI. Changes were
maintained for 3 months. ALPI decreased DIOP
ﬂuctuation in the treated eyes by lowering the maximum
IOP value.
INTRODUCTION
Argon laser peripheral iridoplasty (ALPI) has been
used in the treatment of both acute primary angle
closure (PAC) and angle closure glaucoma
(PACG).1–4 ALPI involves placing a ring of laser
burns on the peripheral iris to contract the iris
stroma near the angle and has been found to be
effective in widening the anterior chamber angles
of eyes presenting with plateau iris syndrome,
where the angle remains occludable after laser per-
ipheral iridotomy (LPI).5 Leung et al6 described a
PACG case in which the angle conﬁguration
changed from occludable to non-occludable follow-
ing ALPI when the angle was measured with time-
domain ocular coherence tomography. Recently, a
widening of the angle at 750 μm from the scleral
spur in 15 non-Caucasian patients with acute PAC
in a single horizontal cross-section was observed
1 hour post-ALPI as an only treatment.7
When treating acute angle closure cases, ALPI
has shown to be more effective in lowering intrao-
cular pressure (IOP) than systemic medications
immediately after an angle closure attack.3 The IOP
control following ALPI was maintained over a
3-month period.8 The mechanism of lowering of
IOP by ALPI is likely to be mainly due to reduction
of the area of trabecular meshwork that is occluded
by the iris. The effect of ALPI on diurnal intraocu-
lar pressure (DIOP) ﬂuctuation has not been inves-
tigated. We have shown previously that there is an
inverse association between DIOP ﬂuctuation and
the dimensions of the anterior chamber angle in
untreated patients with a diagnosis of primary
angle closure suspect (PACS) or PAC in both eyes.9
Considering the use of ALPI in the clinical manage-
ment of patients with occludable angles, it is
important to understand if ALPI affects DIOP ﬂuc-
tuation in addition to the dimensions of the anter-
ior chamber angle.
The purpose of this study was to evaluate tem-
poral change in anterior chamber angle anatomy
following ALPI in eyes with gonioscopically occlud-
able angles post-LPI compared with eyes receiving
no further treatment, using swept-source anterior
segment optical coherence tomography (SS-OCT).
Additionally, the effect of ALPI treatment on DIOP
ﬂuctuation (maximum-minimum IOP) was also
investigated.
METHODS
This was a longitudinal, prospective, double-
randomised research study as part of the
Investigating Management of Primary Angle
Closure and Treatment (IMPACT) study. The aim
of the IMPACT study is to identify factors that
affect risk of conversion between PACS, PAC and
PACG as well as to understand the effects of laser
iridotomy and argon laser iridoplasty on the
dimensions of anterior chamber in those eyes. IOP
and the presence or absence of peripheral anterior
synechiae (PAS) are used to categorise a patient
into differing diagnostic categories. These categor-
ies reﬂect a differing risk for glaucoma-categorised
individuals such as PACS, where only an occludable
angle is present, and PAC, in which PAS and/or a
raised IOP are additionally observed.
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Forty Caucasian consecutive patients newly referred to a hos-
pital glaucoma service with a gonioscopic diagnosis (<180° pos-
terior pigmented trabecular meshwork visible on applanation
gonioscopy) of bilateral PAC, PACS or a combination of both
conditions and no other ocular comorbidity were recruited to
the IMPACT study.
LPI procedures were performed by a single operator (RB)
using a standard technique with superior placement of the iri-
dotomy in a randomly allocated eye of each patient. The ran-
domisation allowed the untreated eye to be used as control and
patients were closely monitored for the duration of the study to
monitor for signs of progression. The mean total power used to
perform the iridotomy was 16.11 mJ (SD 10.8 mJ) and the
mean number of shots was 13 (SD 8.6 mJ). A patent iridotomy
post-LPI was present in all the treated eyes post-LPI and
throughout the study. Patency was tested at the slit-lamp using a
retroillumination technique.
The second randomisation (where eyes with gonioscopically
closed anterior chamber angles were randomised to ALPI or no
further treatment) took place 3 months post-LPI. A gonioscopi-
cally occludable anterior chamber angle was deﬁned as an angle
in which 180° or more of the posterior trabecular meshwork
was obscured on applanation gonioscopy. Gonioscopy examin-
ation was performed by a single examiner (RB) using standar-
dised protocol. Patients were followed after ALPI treatment for
3 months with regular SS-OCT measurements and single IOP
measurements until the ﬁnal visit for DIOP measurements. A
gonioscopically occludable anterior chamber angle was deﬁned
as an angle in which 180° or more of the posterior trabecular
meshwork was obscured on applanation gonioscopy. An over-
view of the patient pathway is given in ﬁgure 1.
Prior to ALPI, one drop of topical pilocarpine (2%) was
instilled into the eye 15 min before the laser procedure which
was performed (all by the same surgeon, RB) using an Abraham
lens (Ocular Instruments, Bellevue, Washington, USA) under
topical anaesthesia. Twenty laser spots were applied using the
following laser settings: 0.5 s duration, 500 m spot size and
180–300 mW power.
Three-dimensional SS-OCT (Casia SS-1000 optical coherence
tomograph; Tomey, Nagoya, Japan) images were obtained on
the same day as the IOP measurements. A three-dimensional
image of the anterior segment of the patient’s eye was obtained
by high-speed scanning without making a contact with the eye.
The infrared measurement laser emitted to the patient’s eye
resulted in the acquired tomographic image of the eye displayed
on the OCT monitor. After measurements were completed, the
data were automatically transferred to the computer.
The scans were taken in darkness (between 0.3 and 0.5 lux)
and the images taken were subsequently analysed using the com-
mercially available software with this instrument. Image acquisi-
tion was always by the same examiner and an ophthalmologist
subspecialising in glaucoma performed all the gonioscopic
examinations (RB). The scleral spur position was identiﬁed
manually by two independent observers with good concord-
ance. The observers were not masked to the intervention and in
case of disagreement, a third observer was asked to review the
position of the scleral spur.
The analysis of SS-OCT images involved calculation of the
following parameters in each eye: the angle opening distance
(AOD), the trabecular-iris angle (TIA), the angle recess area
(ARA) and the trabecular-iris space area (TISA). Eight sectors
(superior, superonasal, nasal, inferonasal, inferior, inferotem-
poral, temporal and superotemporal) for every eye with their
corresponding eight parameters (AOD, ARA, TISA and TIA,
each at 500 and 750 μm) were assessed with the Casia analysis
software (ﬁgure 2).
Following recruitment to the study, participants attended for
IOP measurement every hour from 9:00 to 16:00 (a time
window of 15 min around each clock hour was permitted). IOP
measurements involved Goldmann tonometry (Goldman ton-
ometer AT900; Haag-Streit International, Koeniz, Switzerland)
using disposable prisms to reduce the risk of cross-
contamination. The same tonometer was used for every IOP
measurement for every participant and regular calibration
checks were undertaken, with no calibration errors detected
during the study. Two IOP measurements were taken per eye,
Figure 1 Schematic of IMPACT study pathway. AC, Anterior Chamber, PAC, primary angle closure, PACS, primary angle closure suspects, LPI, laser
peripheral iridotomy, ALPI, argon laser peripheral iridoplasty. Patients with angles no longer judged as occludable on gonioscopy following LPI (red
outline) were excluded from further analysis of effect of ALPI from time of treatment.
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with a maximum of 1 mm Hg difference permitted between
these measurements.
Statistical analyses were performed using SPSS software
Version 20 (IBM, Armonk, New York, USA) and Microsoft
Ofﬁce Excel software (Microsoft, Redmond, Washington, USA)
with p<0.05 values considered statistically signiﬁcant. Angle
width-related measures at different visits before and after LPI
were compared using one-way repeated-measures analysis of
variance, with intervisit difference analysed using Tukey’s
method.
Ethical approval by Cambridgeshire Research Ethics
Committee (REC) for the IMPACT study was obtained on 3
August 2010 (REC Reference 10/H0301/14). The study was
entered on the National Institute for Health Research Clinical
Research Network (NIHR CRN) Portfolio on 9 September
2010 (NIHR CRN Study ID: 8955). The research adhered to
the tenets of the Declaration of Helsinki.
RESULTS
The anterior chamber angles of LPI-treated eyes of 22 patients
remained gonioscopically occludable. These eyes were randomly
assigned to receive ALPI treatment (n=11) or no further treat-
ment (n=11). We observed a statistically widening effect in
1 week in all parameters and sections following ALPI treatment
(measurements obtained for AOD are presented in table 1; mea-
surements obtained for ARA are presented in table 2; for add-
itional angle parameters TISA and TIA, see online
supplementary tables S1 and S2, respectively).
Figure 2 Schematic representation of the eight iridotrabecular angle sections under study. Iridotrabecular angle parameters as measured with the
Casia AS-OCT analysis software. AOD, angle opening distance, ARA, angle recess area, TISA, trabecular-iris space area, TIA, trabecular-iris angle at
500 and 750 μm are highlighted in bright green.
Table 1 Parameters from swept-source optical coherence
tomography-measured anterior chamber angle sections before and






Superior AOD500 0.051 0.105 (0.003) 0.083 (0.015)
Superionasal AOD500 0.057 0.120 (0.001) 0.088 (0.044)
Nasal AOD500 0.135 0.179 (0.002) 0.160 (0.012)
Inferonasal AOD500 0.094 0.184 (0.005) 0.148 (0.001)
Inferior AOD500 0.059 0.101 (0.025) 0.088 (0.054)
Inferotemporal
AOD500
0.094 0.157 (0.004) 0.150 (0.011)
Temporal AOD500 0.099 0.149 (0.003) 0.161 (0.009)
Superotemporal
AOD500
0.065 0.103 (0.031) 0.096 (0.006)
Superior AOD750 0.105 0.118 (0.062) 0.167 (0.011)
Superionasal AOD750 0.093 0.145 (0.004) 0.123 (0.046)
Nasal AOD750 0.191 0.212 (0.059) 0.264 (0.025)
Inferonasal AOD750 0.189 0.257 (0.007) 0.199 (0.05)
Inferior AOD750 0.108 0.208 (0.022) 0.142 (0.063)
Inferotemporal
AOD750
0.187 0.203 (0.036) 0.234 (0.021)
Temporal AOD750 0.149 0.209 (0.004) 0.183 (0.044)
Superotemporal
AOD750
0.050 0.108 (0.006) 0.119 (0.003)
*Mean measurements are shown.
†Mean measurements at the indicated time point and paired t-test p values of
significance (in brackets) when comparing mean angle measurement at the indicated
time point with the pre-ALPI measurement. AOD, angle opening distance.
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For example, at 1 day following ALPI treatment AOD500
increased in the superior sector by 0.054 mm, p=0.003; supero-
nasal sector by 0.062 mm, p=0.001; nasal sector by 0.044 mm,
p=0.002; inferonasal sector by 0.082 mm, p=0.005; inferior
sector by 0.041 mm, p=0.025; inferotemporal sector by
0.063 mm, p=0.004; temporal sector by 0.051 mm, p=0.003
and superotemporal sector by 0.038 mm, p=0.031. This
increase in AOD500 dimensions was maintained over time for
3 months (eg, inferotemporal segment AOD500 increased by
0.063 mm, p=0.004 at 1 day; 0.051 mm, p=0.029 at 1 week;
0.059 mm, p=0.006 at 6 weeks and 0.056 mm, p=0.011 at
12 weeks). The only exception was observed in the inferior
sector, where there was no statistically signiﬁcant difference at
3 months (0.041 mm, p=0.025 at 1 day and 0.029 mm,
p=0.054 at 3 months) (ﬁgure 3).
Similar results were observed for ARA500, TISA500 and
TIA500 (see online supplementary materials). The widening of
angle parameters at 750 μm from the scleral spur was similar to
that observed for all parameters at 500 μm from scleral spur
(ﬁgure 4). A schematic showing temporal changes in angle para-
meters as visualised by SS-OCT is given in ﬁgure 5, showing the
angle prior to ALPI treatment, 1 month after ALPI treatment
and 3 months after ALPI treatment.
DIOP ﬂuctuation prior to ALPI was signiﬁcantly greater than
3 months post-ALPI (mean difference, 1.56 mm Hg, p=0.047).
Further analyses were undertaken in order to determine if this
difference in DIOP ﬂuctuation was due to a difference between
diurnal maxima, diurnal minima or both. In a comparison of
ALPI-treated and ALPI-untreated eyes that had previous iridot-
omy, the maximal values (treated maximum
IOP=19.34 mm Hg, ±1.58 mm Hg at 12 weeks; untreated
maximum IOP=21.15 mm Hg, ±1.52 mm Hg) and the com-
parison of the minimum values (treated minimum
IOP=14.23 mm Hg, ±2.00 mm Hg; untreated minimum
IOP=14.54 mm Hg, ±1.88 mm Hg) conﬁrmed that the differ-
ence in DIOP ﬂuctuation was due to maximum values rather
than minimum values (ﬁgure 6).
Analysis of covariance comparing ALPI-treated eyes with the
fellow eyes, which received no laser treatment in the study,
showed no statistically signiﬁcant differences in comparison to
the DIOP minima between groups (mean difference between
minima DIOP=0.31 mm Hg; p=0.058). However, in a com-
parison of the DIOP maxima, the mean difference between
groups was found to be statistically signiﬁcant of 1.87 mm Hg,
p=0.026) with the untreated eyes exhibiting higher average
maximum IOP measurements.
DISCUSSION
All angle parameters under study increased following LPI as
measured by SS-OCT prior to the ALPI randomisation (data
submitted elsewhere for publication). In the eyes that underwent
ALPI due to the angle remaining gonioscopically occludable,
following the ALPI treatment all eyes changed from an
Table 2 Parameters from swept-source OCT-measured anterior







Superior ARA500 0.018 0.046 (0.020) 0.036 (0.013)
Superonasal ARA500 0.033 0.063 (0.044) 0.051 (0.049)
Nasal ARA500 0.072 0.108 (0.012) 0.89 (0.017)
Inferonasal ARA500 0.052 0.088 (0.019) 0.072 (0.045)
Inferior ARA500 0.023 0.069 (0.029) 0.042 (0.049)
Inferotemporal
ARA500
0.059 0.097 (0.016) 0.089 (0.006)
Temporal ARA500 0.055 0.091 (0.035) 0.085 (0.019)
Superotemporal
ARA500
0.028 0.055 (0.025) 0.036 (0.068)
Superior ARA750 0.038 0.087 (0.020) 0.69 (0.044)
Superionasal ARA750 0.053 0.113 (0.022) 0.079 (0.035)
Nasal ARA750 0.116 0.180 (0.065) 0.163 (0.040)
Inferonasal ARA750 0.091 0.163 (0.016) 0.128 (0.051)
Inferior ARA750 0.041 0.133 (0.021) 0.051 (0.021)
Inferotemporal
ARA750
0.101 0.168 (0.044) 0.143 (0.007)
Temporal ARA750 0.088 0.150 (0.002) 0.127 (0.013)
Superotemporal
ARA750
0.050 0.101 (0.043) 0.089 (0.003)
*Mean measurements are shown.
†Mean measurements at the indicated time point and paired t-test p values of
significance (in brackets) when comparing mean angle measurement at the indicated
time point with the pre-ALPI measurement. ARA, angle recess area.
Figure 3 Changes in angle opening
distance at 500 μm from scleral spur in
all eight sections of the anterior
chamber angle (11 eyes) in argon laser
peripheral iridoplasty-treated eyes
measured with swept-source optical
coherence tomography in dark
conditions.
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occludable gonisocopic conﬁguration 2 weeks prior to treatment
to a non-occludable conﬁguration maintained for 6 weeks fol-
lowing treatment. We observed a statistically signiﬁcant increase
in all angle parameters in all eight sectors under study following
ALPI. Leung et al6 observed changes in one eye before and after
ALPI using OCT imaging, but these changes were not quanti-
ﬁed. Recently, Sng et al7 evaluated AOD750 and TISA750 para-
meters in acute PAC eyes following ALPI treatment using time
domain OCT. They observed an increase in both of these para-
meters, with measurements taken in one meridian (nasal-
temporal) in a single evaluation at 1 hour post-ALPI. The
increase in all eight angle parameters in our study was statistic-
ally signiﬁcant and the observed changes were maintained in
seven of the eight sectors for at least 3 months following ALPI.
Some regression of angle parameters was observed at 3 months
following ALPI, but the changes observed were not statistically
signiﬁcant. This is interesting as although the angle parameters
remained stable up to 3 months, a longer follow-up may show
eventual decrease of the widening effect of ALPI over time.
Therefore, a limitation of this study is the length of follow-up
necessitated by monitoring the untreated eye as well as not
masking the observers to the procedure due to the nature of the
study data collection. The only exception was observed in the
inferior sector, where a regression towards the baseline was
observed for all parameters. It is unclear what might have
accounted for the regression in one sector only, but it is possible
that it could result from a gravitational effect or alternatively
inﬂuenced by the positioning of the inferior sector opposite the
existing iridotomy site, which may alter the stiffness or ﬂexibil-
ity of the iris inferiorly.
Chew and Yeo1 investigated the IOP levels of 11 ALPI-treated
PACG participants whose angles remained occludable following
LPI. They observed an initial reduction of IOP during the ﬁrst
week post-treatment, but a ﬁnal comparison with baseline at
6 months following treatment showed a maintained decrease in
IOP in only seven of the treated eyes. However, it is difﬁcult to
compare these results with our data as the time of day for the
IOP assessment was not speciﬁed, their patients had PACG and
it was not evident that the timing of the IOP measurement was
kept constant from visit to visit. Attention to this detail has been
demonstrated to reduce the intervisit variability in IOP mea-
sures.10 Similar limitations may apply in a recent study by Sun
et al,11 where 158 PAC/PACG participants were randomised
into two groups as follows: (1) LPI alone or (2) LPI followed by
ALPI. The IOP in the study was measured at baseline and at
seven more visits during the following year. The authors report
a reduction in absolute IOP of approximately 6.7 mm Hg in the
LPI-treated group and 7.8 mmHg in the LPI plus ALPI group
12 months following the laser treatment. However, it is not
clear if these IOP measurements were taken at the same time of
the day as in the prelaser visit and therefore whether the
observed reduction in IOP following the laser procedures would
fall within the limits of the patient’s usual diurnal IOP ﬂuctu-
ation. Lee et al12 randomised one eye to receive LPI and the
fellow eye to receive LPI plus ALPI (same setting) in patients
with bilateral PACS and reported that the anterior chamber
depth measured at 4–6 mm from the centre of the eye was sig-
niﬁcantly different between the two treatment groups. The mea-
surements were performed 1 week after the procedure and
assessed with Pentacam. No statistically signiﬁcant differences in
Figure 4 Changes in angle opening
distance at 750 μm from scleral spur in
all eight sections of the anterior
chamber angle (11 eyes) in argon laser
peripheral iridoplasty-treated eyes
measured with swept-source optical
coherence tomography in dark
conditions.
Figure 5 Temporal changes in angle
parameters as visualised by SS-OCT.
(A) Prior to argon laser peripheral
iridoplasty (ALPI) treatment, (B)
1 month after ALPI treatment, (C)
3 months after ALPI treatment.
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IOP measurements were found between baseline and 1 hour,
1 day, 1 week, 1 month and 3 months post-treatment. However,
the time of IOP measurement again was not speciﬁed. A recent
study by Narayanaswamy et al13 reported that in eyes with per-
sistent appositional angle closure and raised IOP, ALPI reduced
IOP on average by 4.9 mm Hg and in 35% of the patient
achieved IOP of <21 mm Hg without medication. However,
when assessed at 1 year following treatment, ALPI was asso-
ciated with higher failure rates and lower IOP reduction com-
pared with medical treatment. The comparison of their results
with the changes we observe in the angle parameters will be dif-
ﬁcult due to the shorter follow-up time and smaller number of
patients in our study.
In this study, we have demonstrated that ALPI is effective in
lowering DIOP ﬂuctuation by 1.56 mm Hg (p=0.047) at
12 weeks post-treatment compared with before treatment. The
difference in DIOP ﬂuctuation was due to the lower maximum
measurements in the ALPI group (1.87 mm Hg, p=0.026) com-
pared with the occludable post-LPI group. Furthermore, in our
study the ALPI-treated group of eyes showed the lowest DIOP
ﬂuctuation compared with the non-treated control eyes, eyes
deemed not occludable post-LPI and eyes that were occludable
post-LPI, demonstrating that ALPI signiﬁcantly reduces DIOP
ﬂuctuation.
CONCLUSION
ALPI increased all angle parameters under investigation in all
eight sections in eyes that remained occludable post-LPI. The
changes in angle dimension detected using SS-OCT were also
conﬁrmed on gonioscopy. The increase in angle parameters was
maintained for 12 weeks with the exception of the inferior
segment where some regression in the evaluated parameters was
observed at 12 weeks. The ﬁnding that ALPI signiﬁcantly
widens the anterior chamber angle circumferentially may confer
protection from the onset or progression of existing damage to
the trabecular meshwork. The reduction in DIOP ﬂuctuation
caused by the ALPI is likely to be related to these changes in
anterior chamber dimensions.
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